We are live on ! Find out more
XBIT icon

XBiotech

55 hedge funds and large institutions have $14.5M invested in XBiotech in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 22 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

4% more funds holding

Funds holding: 5355 (+2)

0.79% less ownership

Funds ownership: 15.47%14.69% (-0.79%)

22% less capital invested

Capital invested by funds: $18.6M → $14.5M (-$4.12M)

59% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 22

Holders
55
Holders Change
+2
Holders Change %
+3.77%
% of All Funds
0.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
9
Reduced
22
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
S
51
Sachetta
Massachusetts
$324
EWA
52
EverSource Wealth Advisors
Alabama
$42 +$45 +13 New
TWD
53
True Wealth Design
Ohio
$17 +$17 +5 New
SS
54
SBI Securities
Japan
$3
VF
55
Virtu Financial
New York
-$58K -14,735 Closed
Group One Trading
56
Group One Trading
Illinois
-$29.6K -7,500 Closed
GI
57
GAMMA Investing
California
-$596 -151 Closed
US Bancorp
58
US Bancorp
Minnesota
-$395 -100 Closed
Citadel Advisors
59
Citadel Advisors
Florida
-$51 -13 Closed
IA
60
IFP Advisors
Florida
-$8 -2 Closed
AW
61
Avion Wealth
Texas
+$248 +72 New

XBIT Hedge Fund Activity: Q1 2025 in Review

55 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q1 2025, worth a combined $14.5M — down 22% from $18.6M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new XBIT positions and 6 closed out — a net gain of 2 holders — while 9 added to existing stakes and 22 trimmed.

The largest buyer was Two Sigma Advisers, opening a new position worth an estimated $60K. The largest seller was Millennium Management, cutting an estimated $625K.

  • 55 institutional investors held XBiotech (XBIT) as of Q1 2025, up from 53 in Q4 2024.
  • Funds reported $14.5M of XBiotech stock for Q1 2025, down 22% quarter-over-quarter.
  • 8 funds opened new XBiotech positions in Q1 2025 and 6 closed out, a net change of +2 holders.
  • The largest XBiotech buyer in Q1 2025 was Two Sigma Advisers, an estimated $60K added.
  • The largest XBiotech seller in Q1 2025 was Millennium Management, an estimated $625K sold.

Based on aggregated 13F filings for Q1 2025.